Press release
Kidney Cancer Drugs Market 2019 Top Clinical Manufacturers (Abbott Laboratories, Glaxosmithkline, Novartis, Bayer, Active Biotech, Amgen, Cipla, Genentech, Prometheus Laboratories, Exelixis, Onyx Pharmaceuticals, Aveo Pharmaceuticals, Immatics Biotechnolo
2019 Global Kidney Cancer Drugs Market to 2025
In 2018, the global Kidney Cancer Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
Get 108 Pages Sample PDF Brochure of this report at https://decisionmarketreports.com/request-sample?productID=959485
The key players covered in this study
• Pfizer
• Abbott Laboratories
• Glaxosmithkline PLC
• Novartis AG
• Bayer AG
• Active Biotech
• Amgen
• Cipla Limited
• F. Hoffmann-La Roche
• Genentech
• Prometheus Laboratories
• Exelixis
• Onyx Pharmaceuticals
• Aveo Pharmaceuticals
• Immatics Biotechnologies
Market segment by Type, the product can be split into
• Nexavar (Sorafenib)
• Sutent (Sunitinib)
• Afinitor (Everolimus)
• Votrient (Pazopanib)
• Avastin (Bevacizumab)
• Inlyta (Axitinib)
• Torisel (Temsirolimus)
• Proleukin (Aldesleukin)
• Other
Market segment by Application, split into
• Hospitals
• Clinics
• Research Center
• Other
Market segment by Regions/Countries, this report covers
• United States
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America
Browse Complete Report with Table of Content at https://decisionmarketreports.com/market-reports/959485/global-kidney-cancer-drugs-market
The study objectives of this report are:
• To analyze global Kidney Cancer Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Kidney Cancer Drugs development in United States, Europe and China.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Kidney Cancer Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
For Better Insights help@decisionmarketreports.com
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Kidney Cancer Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Nexavar (Sorafenib)
1.4.3 Sutent (Sunitinib)
1.4.4 Afinitor (Everolimus)
1.4.5 Votrient (Pazopanib)
1.4.6 Avastin (Bevacizumab)
1.4.7 Inlyta (Axitinib)
1.4.8 Torisel (Temsirolimus)
1.4.9 Proleukin (Aldesleukin)
1.4.10 Other
1.5 Market by Application
1.5.1 Global Kidney Cancer Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Center
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Kidney Cancer Drugs Market Size
2.2 Kidney Cancer Drugs Growth Trends by Regions
2.2.1 Kidney Cancer Drugs Market Size by Regions (2014-2025)
2.2.2 Kidney Cancer Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Kidney Cancer Drugs Market Size by Manufacturers
3.1.1 Global Kidney Cancer Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Kidney Cancer Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Kidney Cancer Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Kidney Cancer Drugs Key Players Head office and Area Served
3.3 Key Players Kidney Cancer Drugs Product/Solution/Service
3.4 Date of Enter into Kidney Cancer Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Kidney Cancer Drugs Market Size by Type (2014-2019)
4.2 Global Kidney Cancer Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Kidney Cancer Drugs Market Size (2014-2019)
5.2 Kidney Cancer Drugs Key Players in United States
5.3 United States Kidney Cancer Drugs Market Size by Type
5.4 United States Kidney Cancer Drugs Market Size by Application
6 Europe
6.1 Europe Kidney Cancer Drugs Market Size (2014-2019)
6.2 Kidney Cancer Drugs Key Players in Europe
6.3 Europe Kidney Cancer Drugs Market Size by Type
6.4 Europe Kidney Cancer Drugs Market Size by Application
7 China
7.1 China Kidney Cancer Drugs Market Size (2014-2019)
7.2 Kidney Cancer Drugs Key Players in China
7.3 China Kidney Cancer Drugs Market Size by Type
7.4 China Kidney Cancer Drugs Market Size by Application
8 Japan
8.1 Japan Kidney Cancer Drugs Market Size (2014-2019)
8.2 Kidney Cancer Drugs Key Players in Japan
8.3 Japan Kidney Cancer Drugs Market Size by Type
8.4 Japan Kidney Cancer Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Kidney Cancer Drugs Market Size (2014-2019)
9.2 Kidney Cancer Drugs Key Players in Southeast Asia
9.3 Southeast Asia Kidney Cancer Drugs Market Size by Type
9.4 Southeast Asia Kidney Cancer Drugs Market Size by Application
10 India
10.1 India Kidney Cancer Drugs Market Size (2014-2019)
10.2 Kidney Cancer Drugs Key Players in India
10.3 India Kidney Cancer Drugs Market Size by Type
10.4 India Kidney Cancer Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Kidney Cancer Drugs Market Size (2014-2019)
11.2 Kidney Cancer Drugs Key Players in Central & South America
11.3 Central & South America Kidney Cancer Drugs Market Size by Type
11.4 Central & South America Kidney Cancer Drugs Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Kidney Cancer Drugs Introduction
12.1.4 Pfizer Revenue in Kidney Cancer Drugs Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Abbott Laboratories
12.2.1 Abbott Laboratories Company Details
12.2.2 Company Description and Business Overview
12.2.3 Kidney Cancer Drugs Introduction
12.2.4 Abbott Laboratories Revenue in Kidney Cancer Drugs Business (2014-2019)
12.2.5 Abbott Laboratories Recent Development
12.3 Glaxosmithkline PLC
12.3.1 Glaxosmithkline PLC Company Details
12.3.2 Company Description and Business Overview
12.3.3 Kidney Cancer Drugs Introduction
12.3.4 Glaxosmithkline PLC Revenue in Kidney Cancer Drugs Business (2014-2019)
12.3.5 Glaxosmithkline PLC Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Company Details
12.4.2 Company Description and Business Overview
12.4.3 Kidney Cancer Drugs Introduction
12.4.4 Novartis AG Revenue in Kidney Cancer Drugs Business (2014-2019)
12.4.5 Novartis AG Recent Development
12.5 Bayer AG
12.5.1 Bayer AG Company Details
12.5.2 Company Description and Business Overview
12.5.3 Kidney Cancer Drugs Introduction
12.5.4 Bayer AG Revenue in Kidney Cancer Drugs Business (2014-2019)
12.5.5 Bayer AG Recent Development
12.6 Active Biotech
12.6.1 Active Biotech Company Details
12.6.2 Company Description and Business Overview
12.6.3 Kidney Cancer Drugs Introduction
12.6.4 Active Biotech Revenue in Kidney Cancer Drugs Business (2014-2019)
12.6.5 Active Biotech Recent Development
12.7 Amgen
12.7.1 Amgen Company Details
12.7.2 Company Description and Business Overview
12.7.3 Kidney Cancer Drugs Introduction
12.7.4 Amgen Revenue in Kidney Cancer Drugs Business (2014-2019)
12.7.5 Amgen Recent Development
12.8 Cipla Limited
12.8.1 Cipla Limited Company Details
12.8.2 Company Description and Business Overview
12.8.3 Kidney Cancer Drugs Introduction
12.8.4 Cipla Limited Revenue in Kidney Cancer Drugs Business (2014-2019)
12.8.5 Cipla Limited Recent Development
12.9 F. Hoffmann-La Roche
12.9.1 F. Hoffmann-La Roche Company Details
12.9.2 Company Description and Business Overview
12.9.3 Kidney Cancer Drugs Introduction
12.9.4 F. Hoffmann-La Roche Revenue in Kidney Cancer Drugs Business (2014-2019)
12.9.5 F. Hoffmann-La Roche Recent Development
12.10 Genentech
12.10.1 Genentech Company Details
12.10.2 Company Description and Business Overview
12.10.3 Kidney Cancer Drugs Introduction
12.10.4 Genentech Revenue in Kidney Cancer Drugs Business (2014-2019)
12.10.5 Genentech Recent Development
12.11 Prometheus Laboratories
12.12 Exelixis
12.13 Onyx Pharmaceuticals
12.14 Aveo Pharmaceuticals
12.15 Immatics Biotechnologies
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Request a In-depth Insights PDF Sample Brochure @ https://decisionmarketreports.com/request-sample?productID=959485
About Us
Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.
Contact Us
Gasper James
304, S Jones Blvd,
Las Vegas,
NV 89107, USA
US Toll Free +1-866-605-1052
Email: sales@decisionmarketreports.com
Web: https://decisionmarketreports.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kidney Cancer Drugs Market 2019 Top Clinical Manufacturers (Abbott Laboratories, Glaxosmithkline, Novartis, Bayer, Active Biotech, Amgen, Cipla, Genentech, Prometheus Laboratories, Exelixis, Onyx Pharmaceuticals, Aveo Pharmaceuticals, Immatics Biotechnolo here
News-ID: 1499979 • Views: …
More Releases from Decision Market Reports
Digital Claims Management Market Demand and Trends by Type, Application and Spec …
Global Digital Claims Management Market Forecast 2021-2030 Report provides an in-depth research on the fast-evolving Digital Claims Management Market. The Competitive analysis of the leading companies has been highlighted in the report along with the regional overview & global outlook of the market till 2030.
With a vision to deliver in depth analysis of Global Digital Claims Management Market, MRD has covered extensive analysis of Product Type and Application along with…
Low Power Wide Area Network (LPWAN) Market Worth USD 78 Billion By 2027| AT&T, A …
Low Power Wide Area Network (LPWAN) Market 2021 : The Report Titled on “Low Power Wide Area Network (LPWAN) Market” provides in-depth review of the Growth, Drivers, Potential Challenges, Unique Trends and Opportunities for market participants equip readers to fully comprehend the overall landscape of the Low Power Wide Area Network (LPWAN) industry.
“Global Low Power Wide Area Network (LPWAN) Market” report offers a complete analysis of the market. It will thus via…
Online Therapy Services Market Predicted to Grow by 2025 Competitive Analysis an …
Global Online Therapy Services Market Forecast 2021-2030 Report provides an in-depth research on the fast-evolving Online Therapy Services Market. The Competitive analysis of the leading companies has been highlighted in the report along with the regional overview & global outlook of the market till 2030.
With a vision to deliver in depth analysis of Global Online Therapy Services Market, MRD has covered extensive analysis of Product Type and Application along with…
Global Cardiac Biomarkers Testing Market In-depth Analysis with Strong Applicati …
Global Cardiac Biomarkers Testing Market Forecast 2021-2030 Report provides an in-depth research on the fast-evolving Cardiac Biomarkers Testing Market. The Competitive analysis of the leading companies has been highlighted in the report along with the regional overview & global outlook of the market till 2030.
With a vision to deliver in depth analysis of Global Cardiac Biomarkers Testing Market, MRD has covered extensive analysis of Product Type and Application along with…
More Releases for Kidney
Kidney Balloon Market Growth Drives By Rising Prevalence of Kidney Stone and Oth …
Demand Analysis of Kidney Balloon Market Overview:
Kidney Balloon Market is predicted to grow at a moderate CAGR of 5.2% during the forecast period covering 2022 to 2029. Kidney Balloon Market share is estimated to reach a value of nearly US$ 2.50 Billion by 2029.
The "Kidney Balloon Market" think about 2022, the industry landscape is secured from driving factors to upstream markets and the by and large state of the market.…
Kidney Transplant Market
Kidney Transplant Market describes its growth, size, share, Forecast and trends to 2025
Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease ESRD patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
Kidney Cancer Association Partners with Conquer Cancer Foundation to Fund Kidney …
For over a decade, the Kidney Cancer Association has assisted with funding the Conquer Cancer Foundation of ASCO's Young Investigator Award. The award provides funding to promising doctors to pursue careers in kidney cancer research.
“Conquer Cancer truly appreciates the generous and ongoing support of the Kidney Cancer Association as we work together to advance cutting-edge research and treatments for kidney cancer. We value this partnership which supports kidney cancer research…
Kidney Cancer Drugs Market: Rising Incidence of Kidney Cancer Expected to Boost …
With only a handful of large vendors accounting collectively for a large share, the vendor landscape of the global market for kidney cancer drugs can be viewed as largely consolidated and tough to crack for new vendors, observes Transparency Market Research in a recent report. The level of competition among leading players is also quite stiff.
Among the leading players, Pfizer, Inc. accounted for the maximum share in the overall market…
3rd Annual Kidney Congress
On behalf of the Conference Series LLC Ltd and the Organizing committee of Kidney 2018, we are pleased to welcome you to participate in the 3rd Annual Kidney Congress. The conference will be held from October 19 - 20, 2018 in New York, USA
Major scientific sessions:
Kidney Fluid, Electrolytes, Acid-Base Disorders
Acute Kidney Injury (AKI) CKD -Mineral and Bone Disorders
Chronic Kidney Disease (CKD) Kidney and Bladder stones
Dialysis and Renal Care Urology/Urinary Tract Infections
Kidney Transplantation Geriatric-Genetic Kidney…
